You’ve probably heard about the scarcity bias—the more challenging something is to acquire, the more valuable it is, and the more we want it. Premium foods and wild-caught fishery company Rare Foods Australia (ASX: RFA) caters to that bias with ocean floor-matured wine and abalones (typically priced at about $60 per kg at fish markets).
Read More
For the second time this year, pharma company AFT Pharmaceuticals (ASX: AFP) has bagged the US Food and Drug Administration’s (FDA) approval. In March 2023, it was approved for Maxigesic Rapid, a rapid-release tablet for acute pain. This time, it’s for Maxigesic IV, the intravenous form of its patented pain relief medicine. The approval was
Read More
The XJO is expected to edge higher on open this morning following the U.S last night which saw their market retake early session losses to finish flat. U.S futures are also in the red. Yesterday we gave up early session gains, rebounding off 7,100 resistance intraday. This morning we will retest these levels which come
Read More
A wave of tourists from China is expected to land on Australian shores in the coming months as tour groups return for the first time since before the pandemic. Chinese tour groups contributed $581 million to the Australian economy in 2019, providing a great opportunity for digital payments company Novatti Group (ASX: NOV), which has
Read More
As more businesses around the world seek solutions to address unreliable staff and reduce excess payroll expenses, artificial intelligence company UNITH (ASX: UNT) is solving all of these problems for them, signing its most clients in a single quarter to its Digital Human platform. Driving increased commercial activity has been tech advancements made in the
Read More
HealthTech company focused on early detection of breast cancer, Volpara Health (ASX: VHT), has reported a fourth consecutive positive net operating cash flow quarter. As a result, it does not have to submit quarterly ASX updates anymore. What’s better, the Company surpassed its initial guidance by a year and a half. For the quarter ended
Read More